Search results for "Precision"

showing 10 items of 448 documents

Measurement of top-quark polarisation observables and a search for dark matter in single-top-quark production with the ATLAS detector at the LHC

2022

Esta tesis presenta dos análisis diferentes basados en los datos resultantes de colisiones protón-protón a una energía en el centro de masas de 13 TeV recolectados con el detector ATLAS del LHC, correspondientes a una luminosidad integrada de 139 fb$^{-1}$. El primer análisis presenta una medida de secciones eficaces diferenciales normalizadas del canal de producción de quarks top en solitario $t$-channel, donde el quark top se desintegra leptónicamente, como función de los tres ángulos de polarización del leptón para eventos con quarks top y quarks antitop tanto separadamente como de forma inclusiva. Estos observables son particularmente sensibles a efectos de nueva física en el vértice $t…

cross-sectionhigh energyUNESCO::FÍSICA::Física atómica y nuclearUNESCO::FÍSICA::Física atómica y nuclear ::Física atómicapolarisation:FÍSICA::Física atómica y nuclear ::Procesos de colisión [UNESCO]UNESCO::FÍSICA::Física atómica y nuclear ::Haces atómicosdark matterUNESCO::FÍSICA::Física atómica y nuclear ::Procesos de colisión:FÍSICA::Física atómica y nuclear [UNESCO]:FÍSICA [UNESCO]t-channelviolación CPatlasparticle physicslhctop quark:FÍSICA::Física atómica y nuclear ::Física atómica [UNESCO]new physicsUNESCO::FÍSICAxgboostmono-topprecisionParticle Physics - Experiment:FÍSICA::Física atómica y nuclear ::Haces atómicos [UNESCO]análisis multivariado
researchProduct

Molecular markers and endometrial cancer

2022

None

molecular markersprecision medicineendometrial cancerMolecular markerendometrial cancer; molecular markers; precision medicinePrecision medicine.Settore MED/40 - Ginecologia E Ostetricia
researchProduct

Novel Approaches for Glioblastoma Treatment: Focus on Tumor Heterogeneity, Treatment Resistance, and Computational Tools

2019

BACKGROUND: Glioblastoma (GBM) is a highly aggressive primary brain tumor. Currently, the suggested line of action is the surgical resection followed by radiotherapy and treatment with the adjuvant temozolomide (TMZ), a DNA alkylating agent. However, the ability of tumor cells to deeply infiltrate the surrounding tissue makes complete resection quite impossible, and in consequence, the probability of tumor recurrence is high, and the prognosis is not positive. GBM is highly heterogeneous and adapts to treatment in most individuals. Nevertheless, these mechanisms of adaption are unknown. RECENT FINDINGS: In this review, we will discuss the recent discoveries in molecular and cellular heterog…

Cancer Researchmedicine.medical_treatmentDNA Mutational AnalysisBrain tumorBioinformaticsComplete resectionTumor heterogeneityCancer VaccinesMicrotubulesArticleClonal EvolutionMachine LearningGenetic HeterogeneityCancer stem cellAntineoplastic Combined Chemotherapy ProtocolsTumor MicroenvironmentMedicineHumansTreatment resistancePrecision MedicineDNA Modification MethylasesImmune Checkpoint InhibitorsTemozolomideModels Geneticbusiness.industryBrain NeoplasmsTumor Suppressor ProteinsBrainComputational BiologyChemoradiotherapy Adjuvantmedicine.diseasePrognosisRadiation therapyDNA Repair EnzymesOncologyDrug Resistance NeoplasmMutationTumor Suppressor Protein p53businessGlioblastomaGlioblastomamedicine.drug
researchProduct

Endometrial Receptivity Analysis (ERA): data versus opinions

2021

Abstract This article summarises and contextualises the accumulated basic and clinical data on the ERA test and addresses specific comments and opinions presented by the opponent as part of an invited debate. Progress in medicine depends on new technologies and concepts that translate to practice to solve long-standing problems. In a key example, combining RNA sequencing data (transcriptomics) with artificial intelligence (AI) led to a clinical revolution in personalising disease diagnosis and fostered the concept of precision medicine. The reproductive field is no exception. Translation of endometrial transcriptomics to the clinic yielded an objective definition of the limited time period …

0301 basic medicine030219 obstetrics & reproductive medicineendometrial receptivitybusiness.industryNatural cycleHormonal replacement therapyEmbryoimplantation / recurrent implantation failureDiseaseEndometriumPrecision medicineBioinformaticsAcademicSubjects/MED00905Embryo transfer03 medical and health sciences030104 developmental biology0302 clinical medicinemedicine.anatomical_structureDebate ContinuedmedicineendometriumEndometrial receptivitybusinessembryo transferHuman Reproduction Open
researchProduct

Three beta-decaying states in 128In and 130In resolved for the first time using Penning-trap techniques

2020

Isomeric states in 128In and 130In have been studied with the JYFLTRAP Penning trap at the IGISOL facility. By employing state-of-the-art ion manipulation techniques, three different beta-decaying states in 128In and 130In have been separated and their masses measured. JYFLTRAP was also used to select the ions of interest for identification at a post-trap decay spectroscopy station. A new beta-decaying high-spin isomer feeding the isomer in 128Sn has been discovered in 128In at 1797.6(20) keV. Shell-model calculations employing a CD-Bonn potential re-normalized with the perturbative G-matrix approach suggest this new isomer to be a 16⁺ spin-trap isomer. In 130In, the lowest-lying (10⁻) isom…

Nuclear and High Energy PhysicsPenning trapAstronomy & Astrophysics01 natural sciencesIonPhysics Particles & Fieldsbeta-decay spectroscopyIsomersShell model0103 physical sciencesPhysics::Atomic and Molecular ClustersNuclear Experiment010306 general physicsSpectroscopyCouplingPhysicsScience & TechnologyNUCLEI010308 nuclear & particles physicsPhysicsPRECISION MASS-SPECTROMETRYNuclear shell modelR-PROCESSshell modelpenning trapRAMSEY METHODPenning traplcsh:QC1-999Physics NuclearExcited stateBeta (plasma physics)Physical SciencesSHELL-MODELTRANSITION-PROBABILITIESisomersAtomic physicsBeta-decay spectroscopylcsh:PhysicsIon cyclotron resonancePhysics Letters B
researchProduct

ETP/GDOP Behavior Study for N-Sensors Arrays ina Multilateration Radar System

2009

In this paper, we evaluated the ETP (Expected Theoretical Precision) and GDOP (Geometric Dilution Of Precision) enhancement related to the number of sensors in a Multilateration radar system. An introduction about the principles of the Multilateration radar system basis operation is described, then, the formulation for evaluation the ETP/GDOP of the 3D positioning is shown. We observed that the ETP and GDOP enhance with the increase of the number of sensors. A substantial improvement was obtained until nine sensors but, for more sensors that improvement is reduced. Results for a 75km×75km area are shown, including LAM (Local Area Multilateration) and WAM (Wide Area Multilateration) settings…

Dilution of precision3d positioninglcsh:TExpected Theoretical Precision Geometric Dilution of Precision MultilaterationMultilaterationlcsh:TechnologyRadar systemsSystem qualityWide area multilaterationGeographylcsh:TA1-2040Antenna height considerationsexpected theoretical precision geometric dilution of precision multilaterationlcsh:Engineering (General). Civil engineering (General)CartographyRemote sensingITECKNE
researchProduct

Towards precision oncology for HER2 blockade in gastroesophageal adenocarcinoma

2019

Gastroesophageal adenocarcinoma (GEA) represents a very heterogeneous disease and patients in advanced stages have a very poor prognosis. Although several molecular classifications have been proposed, precision medicine for HER2-amplified GEA patients still represents a challenge. Despite improvement in clinical outcomes obtained by adding trastuzumab to first-line platinum-based chemotherapy, no other anti-HER2 agents used first-line or beyond progression have demonstrated any benefit. Several factors contribute to this failure. Among them, variable HER2 amplification assessment, tumour heterogeneity, molecular mechanisms of resistance and microenvironmental factors could limit the effecti…

0301 basic medicineOncologymedicine.medical_specialtyEsophageal NeoplasmsTumour heterogeneityReceptor ErbB-2DiseaseDrug resistanceAdenocarcinomaGastroesophageal Junction AdenocarcinomaGenetic Heterogeneity03 medical and health sciences0302 clinical medicineStomach NeoplasmsTrastuzumabInternal medicineAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumormedicineHumansPrecision Medicineskin and connective tissue diseasesGastroesophageal adenocarcinomabusiness.industryGene AmplificationHematologyPrognosisPrecision medicineProgression-Free SurvivalBlockade030104 developmental biologyOncologyDrug Resistance Neoplasm030220 oncology & carcinogenesisEsophagogastric Junctionbusinessmedicine.drugAnnals of Oncology
researchProduct

Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress

2020

Gastroesophageal adenocarcinoma (GEA) represents a heterogeneous disease and, when diagnosed as locally advanced or metastatic, it is characterized by poor prognosis. During the last few years, several molecular classifications have been proposed to try to personalize treatment for those patients diagnosed with advanced disease. Nevertheless, despite the great effort, precision medicine is still far from being a reality. The improvement in the molecular analysis due to the application of high throughput technologies based on DNA and RNA sequencing has opened a novel scenario leading to the personalization of treatment. The possibility to target epidermal growth factor receptor (HER)2, Claud…

Oncologymedicine.medical_specialtymedicine.medical_treatmentprecision medicinePopulationlcsh:MedicineReviewDisease03 medical and health sciences0302 clinical medicineInternal medicinemedicineEpidermal growth factor receptoreducationadvanced gastric cancer030304 developmental biology0303 health scienceseducation.field_of_studyGastroesophageal adenocarcinomabiologybusiness.industrylcsh:RGeneral MedicineImmunotherapyAdvanced gastric cancerPrecision medicineAdvanced gastric cancer; New drug development; Precision medicineFibroblast growth factor receptor030220 oncology & carcinogenesisbiology.proteinnew drug developmentbusinessJournal of Clinical Medicine
researchProduct

Nanoseconds Timing System Based on IEEE 1588 FPGA Implementation

2019

Clock synchronization procedures are mandatory in most physical experiments where event fragments are readout by spatially dislocated sensors and must be glued together to reconstruct key parameters (e.g. energy, interaction vertex etc.) of the process under investigation. These distributed data readout topologies rely on an accurate time information available at the frontend, where raw data are acquired and tagged with a precise timestamp prior to data buffering and central data collecting. This makes the network complexity and latency, between frontend and backend electronics, negligible within upper bounds imposed by the frontend data buffer capability. The proposed research work describ…

EthernetFOS: Computer and information sciencesNuclear and High Energy PhysicsEye diagram; field-programmable gate arrays (FPGAs); front-end electronics; hardware; synchronization; timing systemfront-end electronicEye diagramtiming systemSerial communicationData bufferNetwork topology01 natural sciencesClock synchronizationNOComputer Science - Networking and Internet ArchitecturePE2_20103 physical sciencesSynchronization (computer science)hardwareElectrical and Electronic EngineeringNetworking and Internet Architecture (cs.NI)010308 nuclear & particles physicsbusiness.industrySettore FIS/01 - Fisica Sperimentalefront-end electronicsNuclear Energy and Engineeringfield-programmable gate arrays (FPGAs)Precision Time ProtocolbusinesssynchronizationComputer hardwareData link layer
researchProduct

Next-generation sequencing: big data meets high performance computing

2017

The progress of next-generation sequencing has a major impact on medical and genomic research. This high-throughput technology can now produce billions of short DNA or RNA fragments in excess of a few terabytes of data in a single run. This leads to massive datasets used by a wide range of applications including personalized cancer treatment and precision medicine. In addition to the hugely increased throughput, the cost of using high-throughput technologies has been dramatically decreasing. A low sequencing cost of around US$1000 per genome has now rendered large population-scale projects feasible. However, to make effective use of the produced data, the design of big data algorithms and t…

0301 basic medicineComputer scienceDistributed computingGenomic researchBig dataTerabyteComputing MethodologiesDNA sequencing03 medical and health sciences0302 clinical medicineDatabases GeneticDrug DiscoveryHumansThroughput (business)PharmacologyGenomebusiness.industryHigh-Throughput Nucleotide SequencingGenomicsSequence Analysis DNAPrecision medicineSupercomputerData scienceCancer treatment030104 developmental biology030220 oncology & carcinogenesisbusinessAlgorithmsDrug Discovery Today
researchProduct